Nomura Holdings’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,500
| Closed | -$196K | – | 1294 |
|
|
2024
Q4 | $196K | Sell |
26,500
-35,189
| -57% | -$260K | ﹤0.01% | 1388 |
|
|
2024
Q3 | $579K | Buy |
61,689
+47,514
| +335% | +$446K | ﹤0.01% | 655 |
|
|
2024
Q2 | $114K | Sell |
14,175
-3,940
| -22% | -$31.6K | ﹤0.01% | 1042 |
|
|
2024
Q1 | $268K | Sell |
18,115
-39,692
| -69% | -$588K | ﹤0.01% | 773 |
|
|
2023
Q4 | $470K | Sell |
57,807
-11,752
| -17% | -$95.5K | ﹤0.01% | 773 |
|
|
2023
Q3 | $316K | Sell |
69,559
-186,500
| -73% | -$849K | ﹤0.01% | 643 |
|
|
2023
Q2 | $1.8M | Sell |
256,059
-115,000
| -31% | -$810K | ﹤0.01% | 305 |
|
|
2023
Q1 | $2.27M | Sell |
371,059
-644,679
| -63% | -$3.94M | 0.01% | 379 |
|
|
2022
Q4 | $6.48M | Buy |
1,015,738
+34,454
| +4% | +$220K | 0.03% | 206 |
|
|
2022
Q3 | $9.41M | Sell |
981,284
-168,117
| -15% | -$1.61M | 0.04% | 176 |
|
|
2022
Q2 | $13.2M | Buy |
+1,149,401
| New | +$13.2M | 0.05% | 134 |
|
|
2021
Q2 | – | Sell |
-12,000
| Closed | -$380K | – | 1717 |
|
|
2021
Q1 | $380K | Buy |
+12,000
| New | +$380K | ﹤0.01% | 1073 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$275K | – | 1018 |
|
|
2020
Q2 | $275K | Buy |
+10,000
| New | +$275K | ﹤0.01% | 698 |
|
|
2019
Q2 | – | Sell |
-91,392
| Closed | -$891K | – | 792 |
|
|
2019
Q1 | $891K | Buy |
91,392
+30,512
| +50% | +$297K | ﹤0.01% | 530 |
|
|
2018
Q4 | $538K | Buy |
+60,880
| New | +$538K | ﹤0.01% | 610 |
|